deltatrials
Unknown OBSERVATIONAL NCT03214263

Identification of New Biomarkers to Promote Personalized Treatment of Patients With Inflammatory Rheumatic Diseases

Identification of New Biomarkers to Improve Diagnostics or Predict Treatment Responses, Adverse Events or Prognosis in Patients With Inflammatory Rheumatic Disease Followed in the Danish Nationwide Quality Registry, DANBIO

Sponsor: Aalborg University Hospital

Conditions Arthritis, Rheumatoid Axial Spondyloarthritis Connective Tissue Diseases Gout Psoriatic Arthritis
Updated 15 times since 2017 Last updated: Jan 8, 2024 Started: May 31, 2015 Primary completion: Dec 31, 2024 Completion: Dec 31, 2024
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Arthritis, Rheumatoid and Axial Spondyloarthritis and is currently ongoing. Aalborg University Hospital leads this study, which shows 15 recorded versions since 2015 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Aug 2017 – ~Apr 2018 · 8 months · monthly snapshot~Apr 2018 – ~May 2018 · 30 days · monthly snapshot~May 2018 – ~Jun 2018 · 31 days · monthly snapshot~Jun 2018 – ~Oct 2018 · 4 months · monthly snapshot~Oct 2018 – ~Jun 2019 · 8 months · monthly snapshot~Jun 2019 – ~Apr 2020 · 10 months · monthly snapshot~Apr 2020 – ~Nov 2020 · 7 months · monthly snapshot~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshot~Jan 2021 – ~Dec 2021 · 11 months · monthly snapshot~Dec 2021 – ~Dec 2022 · 12 months · monthly snapshot~Dec 2022 – ~Feb 2024 · 14 months · monthly snapshot~Feb 2024 – ~Jul 2024 · 5 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Feb 2026 · 17 months · monthly snapshot~Feb 2026 – present · 5 months · monthly snapshot

Change History

15 versions recorded

  1. Feb 2026 — Present [monthly]

    Unknown

    Status: Recruiting → Unknown

  2. Sep 2024 — Feb 2026 [monthly]

    Recruiting

  3. Jul 2024 — Sep 2024 [monthly]

    Recruiting

  4. Feb 2024 — Jul 2024 [monthly]

    Recruiting

  5. Dec 2022 — Feb 2024 [monthly]

    Recruiting

▶ Show 10 earlier versions

  1. Dec 2021 — Dec 2022 [monthly]

    Recruiting

  2. Jan 2021 — Dec 2021 [monthly]

    Recruiting

  3. Nov 2020 — Jan 2021 [monthly]

    Recruiting

  4. Apr 2020 — Nov 2020 [monthly]

    Recruiting

  5. Jun 2019 — Apr 2020 [monthly]

    Recruiting

  6. Oct 2018 — Jun 2019 [monthly]

    Recruiting

  7. Jun 2018 — Oct 2018 [monthly]

    Recruiting

  8. May 2018 — Jun 2018 [monthly]

    Recruiting

  9. Apr 2018 — May 2018 [monthly]

    Recruiting

    Phase: NA → None

  10. Aug 2017 — Apr 2018 [monthly]

    Recruiting NA

    First recorded

May 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Aalborg University Hospital
  • Aarhus University Hospital
  • Copenhagen University Hospital at Herlev
  • Hillerod Hospital, Denmark
  • King Christian X´Hospital for Rheumatic Diseases
  • Odense University Hospital
  • Randers Regional Hospital
  • Rigshospitalet, Denmark
  • Svendborg Hospital
  • Sygehus Lillebaelt
  • University Hospital Bispebjerg and Frederiksberg
  • University Hospital, Gentofte, Copenhagen
  • Zealand University Hospital
Data source: Rigshospitalet, Denmark

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations